Clinical Trials: SEARCH[Study] TILT[Study:StudyFirstPostDate] ALL
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 6447 6448 6449 6450 6451 6452 6453 6454 6455 6456 6457 6458 6459 6460 6461 6462 6463 6464 … 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 Next Last
#
NCTID/Status
Study
Last Changed
322151
NCT00022945
Completed
Completed
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody Plus CHOP For Untreated Mantle Cell Lymphoma
Conditions: Mantle Cell Lymphoma
Intervention: Iodine-131 Anti-B1 Antibody, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone (CHOP)
Conditions: Mantle Cell Lymphoma
Intervention: Iodine-131 Anti-B1 Antibody, Cyclophosphamide, Doxorubicin, Vincristine, And Prednisone (CHOP)
June 23, 2005
322152
NCT00022932
Unknown status
Unknown status
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for Intermediate Grade Non-Hodgkin's Lymphoma Following First Line CHOP
Conditions: Non-Hodgkin's Lymphoma
Intervention: Iodine-131 Anti-B1 Antibody
Conditions: Non-Hodgkin's Lymphoma
Intervention: Iodine-131 Anti-B1 Antibody
June 23, 2005
322153
NCT00022919
Completed
Completed
Analysis of Prostate Cancer Short-Term Cultures Using Molecular Cytogenetic Methods
Conditions: Prostate Cancer
Conditions: Prostate Cancer
March 3, 2008
322154
NCT00022906
Unknown status
Unknown status
Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement
Conditions: Non-Hodgkin's Lymphoma
Intervention: Iodine-131 Anti-B1 Antibody
Conditions: Non-Hodgkin's Lymphoma
Intervention: Iodine-131 Anti-B1 Antibody
June 23, 2005
322155
NCT00022893
Unknown status
Unknown status
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for the Retreatment of Patients With Non-Hodgkin's Lymphoma
Conditions: Non-Hodgkin's Lymphoma
Intervention: Iodine-131 Anti-B1 Antibody
Conditions: Non-Hodgkin's Lymphoma
Intervention: Iodine-131 Anti-B1 Antibody
June 23, 2005
322156
NCT00022880
Unknown status
Unknown status
Safety and Efficacy Study of Iodine-131 Anti-B1 Antibody for Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia
Intervention: Iodine-131 Anti-B1 Antibody
Conditions: Chronic Lymphocytic Leukemia
Intervention: Iodine-131 Anti-B1 Antibody
June 23, 2005
322157
NCT00022867
Completed
Completed
Encouraging Calcium Absorption and Bone Formation During Early Puberty
Conditions: Osteoporosis; Osteopenia
Intervention: Nondigestible Oligosaccharide (NDO)
Conditions: Osteoporosis; Osteopenia
Intervention: Nondigestible Oligosaccharide (NDO)
July 23, 2015
322158
NCT00022854
Completed
Completed
Pain Relief Results After Anterior Cruciate Ligament (ACL) Reconstruction
Conditions: Anterior Cruciate Ligament Rupture
Intervention: Single-injection Femoral Nerve Block, Femoral Nerve Block 60-hour Continuous Injection, Saline (control) Injection Into Femoral Nerve Envelope
Conditions: Anterior Cruciate Ligament Rupture
Intervention: Single-injection Femoral Nerve Block, Femoral Nerve Block 60-hour Continuous Injection, Saline (control) Injection Into Femoral Nerve Envelope
May 2, 2013
322159
NCT00022841
Terminated
Terminated
Prevention of Steroid-Induced Osteoporosis in Children
Conditions: Osteoporosis
Intervention: Pamidronate
Conditions: Osteoporosis
Intervention: Pamidronate
December 14, 2007
322160
NCT00022828
Unknown status
Unknown status
3-D Laser Imaging to Analyze Neck Movement
Conditions: Neck Pain; Manipulation, Spinal
Intervention: 3-D Laser Imaging Device
Conditions: Neck Pain; Manipulation, Spinal
Intervention: 3-D Laser Imaging Device
January 2, 2007
322161
NCT00022815
Completed
Completed
Management of Compartment Syndrome With Ultrafiltration
Conditions: Compartment Syndrome
Intervention: Tissue Ultrafiltration
Conditions: Compartment Syndrome
Intervention: Tissue Ultrafiltration
April 11, 2008
322162
NCT00022802
Terminated
Terminated
Image Guided System for Orthopaedic Surgery
Conditions: Orthopaedic Trauma; Hip Fracture
Intervention: Image-guided Surgical System
Conditions: Orthopaedic Trauma; Hip Fracture
Intervention: Image-guided Surgical System
April 7, 2009
322163
NCT00022776
Completed
Completed
Surgical Versus Nonsurgical Treatment for Spinal Stenosis
Conditions: Spinal Stenosis
Intervention: Surgical Decompression, Physical Therapy
Conditions: Spinal Stenosis
Intervention: Surgical Decompression, Physical Therapy
February 26, 2013
322164
NCT00022789
Completed
Completed
Prevalence of Sleep-Disordered Breathing in Children
Conditions: Lung Diseases; Sleep Apnea Syndromes
Conditions: Lung Diseases; Sleep Apnea Syndromes
March 12, 2014
322165
NCT00022750
Completed
Completed
Randomized Trial of Health Events Costs in Diabetic Blacks
Conditions: Diabetes Mellitus, Type 2
Intervention: Nurse Case Manager And Community Health Worker Team
Conditions: Diabetes Mellitus, Type 2
Intervention: Nurse Case Manager And Community Health Worker Team
January 14, 2010
322166
NCT00021970
Completed
Completed
Modifying Oxidative Damage in WAVE - Ancillary to WAVE
Conditions: Cardiovascular Diseases; Coronary Disease; Heart Diseases
Conditions: Cardiovascular Diseases; Coronary Disease; Heart Diseases
February 29, 2016
322167
NCT00021957
Completed
Completed
ESCAPE Mechanistic Substudies - Ancillary to ESCAPE
Conditions: Cardiovascular Diseases; Heart Diseases; Heart Failure; Heart Failure, Congestive
Conditions: Cardiovascular Diseases; Heart Diseases; Heart Failure; Heart Failure, Congestive
February 17, 2016
322168
NCT00021944
Completed
Completed
Non-Traditional Cardiovascular Risk Factors in Type 2 Diabetes Mellitus - Ancillary to VA Study of Glycemic Control
Conditions: Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Non-insulin Dependent; Heart Diseases
Conditions: Atherosclerosis; Cardiovascular Diseases; Diabetes Mellitus; Diabetes Mellitus, Non-insulin Dependent; Heart Diseases
July 28, 2016
322169
NCT00021931
Completed
Completed
Modification of Allergic Immunologic Response by Leukotriene Antagonists - Ancillary to ACRN IMPACT
Conditions: Asthma; Lung Diseases
Conditions: Asthma; Lung Diseases
March 15, 2016
322170
NCT00021918
Completed
Completed
Serum Total Homocysteine and C-Reactive Protein - Ancillary to IDNT
Conditions: Cardiovascular Diseases; Atherosclerosis; Heart Diseases; Diabetes Mellitus, Non-insulin Dependent; Hypertension; Diabetes Mellitus
Conditions: Cardiovascular Diseases; Atherosclerosis; Heart Diseases; Diabetes Mellitus, Non-insulin Dependent; Hypertension; Diabetes Mellitus
February 17, 2016
322171
NCT00021905
Completed
Completed
Atrial Fibrillation Incidence, Risk Factors and Genetics
Conditions: Atrial Fibrillation; Cardiovascular Diseases; Heart Diseases; Hypertension; Cerebrovascular Accident; Arrhythmia
Conditions: Atrial Fibrillation; Cardiovascular Diseases; Heart Diseases; Hypertension; Cerebrovascular Accident; Arrhythmia
July 23, 2008
322172
NCT00021892
Completed
Completed
Ventricular Matrix Remodeling: Correlates and Prognosis
Conditions: Heart Diseases; Heart Failure, Congestive; Cardiovascular Diseases; Heart Failure
Conditions: Heart Diseases; Heart Failure, Congestive; Cardiovascular Diseases; Heart Failure
February 20, 2014
322173
NCT00021879
Completed
Completed
Visceral Adiposity and CVD Risk in Women
Conditions: Cardiovascular Diseases; Heart Diseases; Obesity; Diabetes Mellitus
Conditions: Cardiovascular Diseases; Heart Diseases; Obesity; Diabetes Mellitus
February 17, 2016
322174
NCT00021866
Completed
Completed
Developmental Effects On Children Of Women Who Take Antiepileptic Drugs During Pregnancy
Conditions: Epilepsy; Seizure; Cognition Disorders
Intervention: Differential Abilities Scale, Neuropsychological Testing
Conditions: Epilepsy; Seizure; Cognition Disorders
Intervention: Differential Abilities Scale, Neuropsychological Testing
November 8, 2013
322175
NCT00021853
Completed
Completed
Motor Training to Treat Hand Dystonia
Conditions: Focal Dystonia
Intervention: Constraint-induced Movement Therapy
Conditions: Focal Dystonia
Intervention: Constraint-induced Movement Therapy
March 3, 2008
322176
NCT00021840
Completed
Completed
Genetic Epidemiology of Asthma in Costa Rica
Conditions: Asthma; Lung Diseases
Conditions: Asthma; Lung Diseases
August 1, 2014
322177
NCT00021827
Completed
Completed
PTHrP and Osteoporosis
Conditions: Osteoporosis
Intervention: Parathyroid Hormone-related Protein Or ''PTHrP''
Conditions: Osteoporosis
Intervention: Parathyroid Hormone-related Protein Or ''PTHrP''
March 1, 2010
322178
NCT00021814
Completed
Completed
Medical Therapy of Prostatic Symptoms
Conditions: Prostatic Hyperplasia; Prostatic Hypertrophy, Benign
Intervention: Doxazosin, Finasteride, Doxazosin Placebo, Finasteride Placebo
Conditions: Prostatic Hyperplasia; Prostatic Hypertrophy, Benign
Intervention: Doxazosin, Finasteride, Doxazosin Placebo, Finasteride Placebo
September 26, 2018
322179
NCT00021801
Completed
Completed
Islet Cell Transplantation Alone and CD34+ Enriched Bone Marrow Cell Infusion in Patients With Diabetes Mellitus: Steroid-Free Regimen
Conditions: Type 1 Diabetes Mellitus
Intervention: Islet Cell Transplantation
Conditions: Type 1 Diabetes Mellitus
Intervention: Islet Cell Transplantation
March 1, 2010
322180
NCT00021788
Completed
Completed
Islet Cell Transplantation Alone in Patients With Type I Diabetes Mellitus: Steroid-free Immunosuppression
Conditions: Diabetes Mellitus, Type 1
Intervention: Islet Cell Transplantation
Conditions: Diabetes Mellitus, Type 1
Intervention: Islet Cell Transplantation
July 7, 2010
322181
NCT00021749
Completed
Completed
Phase I/II Study of Genasense in Patients With Chronic Lymphocytic Leukemia
Conditions: Chronic Lymphocytic Leukemia; CLL
Intervention: Oblimerson Sodium, G3139
Conditions: Chronic Lymphocytic Leukemia; CLL
Intervention: Oblimerson Sodium, G3139
November 10, 2009
322182
NCT00021736
Completed
Completed
Phase II/III Study of Anti-VEGF in Neovascular AMD
Conditions: Macular Degeneration; Choroidal Neovascularization
Intervention: EYE001 Anti-VEGF Aptamer
Conditions: Macular Degeneration; Choroidal Neovascularization
Intervention: EYE001 Anti-VEGF Aptamer
June 23, 2005
322183
NCT00021723
Terminated
Terminated
Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease
Conditions: Alzheimer's Disease
Intervention: AN-1792 Also Known As AIP-001
Conditions: Alzheimer's Disease
Intervention: AN-1792 Also Known As AIP-001
September 22, 2009
322184
NCT00021710
Completed
Completed
Motor Learning in Stroke Patients and Healthy Volunteers
Conditions: Stroke; Healthy
Conditions: Stroke; Healthy
March 3, 2008
322185
NCT00021697
Completed
Completed
Safety/Efficacy of AVP-923 in the Treatment of Emotional Lability (Uncontrolled Crying & Laughing) in Patients With ALS
Conditions: Amyotrophic Lateral Sclerosis
Intervention: AVP-923
Conditions: Amyotrophic Lateral Sclerosis
Intervention: AVP-923
July 13, 2016
322186
NCT00021658
Completed
Completed
Effects of Pesticide Exposure on Neurodevelopment/Growth/Respiratory Health
Conditions: Environmental Exposure
Intervention: Pesticide Application Procedures
Conditions: Environmental Exposure
Intervention: Pesticide Application Procedures
September 26, 2014
322187
NCT00021645
Completed
Completed
Vitamin E to Treat Uveitis-Associated Macular Edema
Conditions: Cystoid Macular Edema; Uveitis
Intervention: Vitamin E
Conditions: Cystoid Macular Edema; Uveitis
Intervention: Vitamin E
March 3, 2008
322188
NCT00021580
Unknown status
Unknown status
Modification of the "Edmonton Protocol" to Allow for Successful Islet Transplantation From a Single Pancreas and Extension of the "Edmonton Protocol" to Kidney Transplant Recipients
Conditions: Diabetes Mellitus
Intervention: Human Cadaveric Islet Cell Transplantation
Conditions: Diabetes Mellitus
Intervention: Human Cadaveric Islet Cell Transplantation
June 23, 2005
322189
NCT00021567
Completed
Completed
A Randomized, Double-Blinded, Placebo-Controlled, Phase II Inhaled Interferon Gamma-1b and Antimycobacterials to Treat Pulmonary Mycobacterium Avium Complex Infections
Conditions: Mycobacterium Avium-Intracellulare Infection
Intervention: Interferon Gamma For Aerosol
Conditions: Mycobacterium Avium-Intracellulare Infection
Intervention: Interferon Gamma For Aerosol
March 3, 2008
322190
NCT00021541
Completed
Completed
R115777 to Treat Children With Neurofibromatosis Type 1 and Progressive Plexiform Neurofibromas
Conditions: Neurofibroma, Plexiform; Neurofibromatosis Type I
Intervention: Tipifarnib, Placebo
Conditions: Neurofibroma, Plexiform; Neurofibromatosis Type I
Intervention: Tipifarnib, Placebo
March 15, 2018
322191
NCT00021528
Completed
Completed
Sequenced Treatment Alternatives to Relieve Depression (STAR*D)
Conditions: Depression
Intervention: Citalopram, BuproprionSR, Buspirone, Lithium, Mirtazapine, Nortriptyline, Sertraline, Tranylcypromine, VenlafaxineXR, Cognitive Therapy, T3 (Triiodothyronine)
Conditions: Depression
Intervention: Citalopram, BuproprionSR, Buspirone, Lithium, Mirtazapine, Nortriptyline, Sertraline, Tranylcypromine, VenlafaxineXR, Cognitive Therapy, T3 (Triiodothyronine)
September 24, 2009
322192
NCT00021502
Completed
Completed
Safety and Efficacy of PHP in the Treatment of Shock Associated With Systemic Inflammatory Response Syndrome (SIRS)
Conditions: Shock; Systemic Inflammatory Response Syndrome
Intervention: Pyridoxalated Hemoglobin Polyoxyethylene Conjugate (PHP)
Conditions: Shock; Systemic Inflammatory Response Syndrome
Intervention: Pyridoxalated Hemoglobin Polyoxyethylene Conjugate (PHP)
August 13, 2009
322193
NCT00021476
Completed
Completed
Preventing Chronic Whiplash Pain
Conditions: Whiplash Injuries
Intervention: Behavioral Treatments, Physical Therapy
Conditions: Whiplash Injuries
Intervention: Behavioral Treatments, Physical Therapy
August 9, 2013
322194
NCT00021437
Completed
Completed
Biological Significance of the Bloom's Syndrome Protein
Conditions: Bloom Syndrome
Conditions: Bloom Syndrome
June 23, 2005
322195
NCT00018902
Completed
Completed
Treatment of SSRI-Resistant Depression In Adolescents (TORDIA)
Conditions: Depression
Intervention: Fluoxetine, Venlafaxine, Cognitive Behavioral Therapy (CBT), Citalopram
Conditions: Depression
Intervention: Fluoxetine, Venlafaxine, Cognitive Behavioral Therapy (CBT), Citalopram
March 11, 2014
322196
NCT00018889
Recruiting
Recruiting
Phenotype/Genotype Correlations in Movement Disorders
Conditions: Movement Disorder
Conditions: Movement Disorder
November 19, 2019
322197
NCT00018876
Completed
Completed
Low-Dose Radiation to Prevent Complications of Back Surgery
Conditions: Failed Back Surgery Syndrome; Postlaminectomy Syndrome; Postdiscectomy Epidural Fibrosis
Intervention: Lumbar Nerve Root Decompression, Preoperative Low-dose External Beam Radiation
Conditions: Failed Back Surgery Syndrome; Postlaminectomy Syndrome; Postdiscectomy Epidural Fibrosis
Intervention: Lumbar Nerve Root Decompression, Preoperative Low-dose External Beam Radiation
June 6, 2013
322198
NCT00018863
Unknown status
Unknown status
Treatment of Attention Deficit Hyperactivity Disorder in Preschool-Age Children (PATS)
Conditions: Attention Deficit Disorder With Hyperactivity
Intervention: Methylphenidate
Conditions: Attention Deficit Disorder With Hyperactivity
Intervention: Methylphenidate
November 1, 2013
322199
NCT00018850
Completed
Completed
5HT3 Antagonism and Auditory Gating in Schizophrenia
Conditions: Schizophrenia
Intervention: Ondansetron, Neuropsychological Testing, Nicotine, Haloperidol
Conditions: Schizophrenia
Intervention: Ondansetron, Neuropsychological Testing, Nicotine, Haloperidol
January 20, 2009
322200
NCT00018837
Completed
Completed
Brief Hospitalization for Schizophrenia: Strategies to Improve Treatment Outcome
Conditions: Schizophrenia; Schizophrenic Disorder
Intervention: Community Re-Entry Program: What Is Schizophrenia
Conditions: Schizophrenia; Schizophrenic Disorder
Intervention: Community Re-Entry Program: What Is Schizophrenia
January 20, 2009
First Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 … 6424 6425 6426 6427 6428 6429 6430 6431 6432 6433 6434 6435 6436 6437 6438 6439 6440 6441 6442 6443 6444 6445 6446 6447 6448 6449 6450 6451 6452 6453 6454 6455 6456 6457 6458 6459 6460 6461 6462 6463 6464 … 6476 6477 6478 6479 6480 6481 6482 6483 6484 6485 6486 6487 6488 6489 6490 6491 6492 6493 6494 6495 Next Last
Last Updated
The last updated date is the most recent date when changes to a clinical trial were
submitted to ClinicalTrials.gov. There is often a delay of a few days before the
updated trial is available on the clinical trials website.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Specify a From date to find the most recently changed trials. Specify both From and To dates to find trials changed during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
First Received
The first received date is the date when the clinical trial was first submitted
to ClinicalTrials.gov. There is often a delay of a few days before the
trial is available on the clinical trials website.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Clinical trial records are often updated after they have been published. The first received, last updated, start, and end dates are all displayed in the full text view of the clinical trial.
Specify a From date to find the most recent trials. Specify both From and To dates to find trials submitted during a certain period. If no dates are given, all trials will be included.
Dates should be given in a MM/DD/YYYY format, as in 1/1/2006 or 8/17/2004.
Safety Issue
If selected, restricts search results to those studies which have
an outcome measure designated as a safety issue. Note that this is a
poor estimate of the safety of a treatment or intervention, but it is
all we have now.
Funded By
Studies are supported by one or more organizations called sponsors.
Support includes contributions of facilities, expertise, and/or financial resources.
All sponsors in the database have been assigned one of the following organization types:
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
National Institutes of Health (NIH)
Other U.S. Federal Agency - Food and Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), Department of Veterans Affairs (VA), etc.
Industry - the pharmaceutical companies
University/Organization - all others, including community-based organizations
Click the check box to the left of each organization type that you wish to include in your search. You can select more than one organization type. If you do not select any type, all types will be included.
Study Phase
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Most clinical trials are designated as phase 1, 2, 3, or 4, based on the type of questions
that study is seeking to answer:
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
In Phase 1 (Phase I) clinical trials, researchers test a new drug or treatment in a small group of people (20-80) for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
In Phase 2 (Phase II) clinical trials, the study drug or treatment is given to a larger group of people (100-300) to see if it is effective and to further evaluate its safety.
In Phase 3 (Phase III) clinical trials, the study drug or treatment is given to large groups of people (1,000-3,000) to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
In Phase 4 (Phase IV) clinical trials, post marketing studies delineate additional information including the drug's risks, benefits, and optimal use.
These phases are defined by the Food and Drug Administration in the Code of Federal Regulations.
Click the check box to the left of each study phase that you wish to include in your search. You can select more than one study phase. If you do not select a any phase, all phases will be included.
Age Group
Studies may be designed for participants of particular ages:
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Children (birth-17 yrs old)
Adults (18-65 yrs old)
Senior (66+ yrs old)
Click the check box to the left of each age group that you wish to include in your search. You can select more than one age group. If you do not select a any group, all groups will be included.
Gender
Searches can be restricted to studies which accept female or male participants.
Location Terms
If you are interested in a specific city (such as Los Angeles) or facility
name (such as the Mayo Clinic), enter it as a location term. Not all studies
include this level of detail, but if they do, this will find them.
Countries and States
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state.
Study IDs
Each trial is assigned one or more identification numbers by the institute, agency,
or organization sponsoring the trial. In addition, clinical trials assigns a
unique NCT identifier of the form NCTxxxxxxxx where each x is a numeric digit.
Use this box to search for a trial by NCT identifier or any other study
identification numbers.
Examples:
Examples:
NCT00001789
97-h-0197
ia0006
actg 076
97-h-0197
ia0006
actg 076
Sponsor (Lead)
Use this box to specify the name of an institute, organization, or company that is
conducting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
A search in this area will check only the sponsor field. To also look for collaborators, use the Sponsor/Collaborators search box.
When the Exact Match checkbox is checked, the sponsor name in the study must exactly match the sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Sponsor/Collaborators
Use this box to specify institutes, organizations, or companies that are
conducting or otherwise supporting a trial.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the sponsor is decided by the data provider.
Searching this area will look in both the sponsor field and in the collaborators field. To only look in the sponsor field, use the Sponsor (Lead) search box.
When the Exact Match checkbox is checked, the name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Examples:
National Cancer Institute
Mayo Clinic
Bristol-Myers Squibb
Outcome Measures
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Outcome measures are used to evaluate trial results. For example, an obesity treatment
might be evaluated by a measure of weight loss after 6 months. Measures can also be used
to quantify side effects, such as number of myocardial infarctions,
number of patients with heart arrhythmia, number of suicides, etc.
Use this box to specify an outcome measure used to evaluate trial results.
Examples:
weight loss
heart failure
suicide
Interventions
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Interventions refer to the drug, vaccine, procedure, device, or other potential treatment being studied.
Interventions can also include less intrusive possibilities such as surveys, education, and interviews.
Use this box to specify drugs, devices, procedures, or vaccines used in a trial.
Examples:
clofibrate
cyclosporine
vitamin e
Conditions
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Conditions usually refer to a disease, disorder, syndrome, illness, or injury. In ClinicalTrials.gov,
conditions include any health issue worth studying, such as lifespan, quality of life, health risks, etc.
Use this box to specify the conditions being studied.
Examples:
lupus
heart attack
leukemia
risk factors for breast cancer
Study Type
There are three types of studies available in ClinicalTrials.gov:
There are three types of studies available in ClinicalTrials.gov:
Interventional:
Observational:
Expanded Access:
Studies where individuals are assigned to receive specific interventions.
Participants may receive diagnostic, therapeutic or other types of interventions.
Assignment of the intervention may or may not be random.
Individuals are tracked and biomedical and/or health outcomes are assessed.
Observational:
Studies without an intervention.
Studies where biomedical and/or health outcomes are assessed in a pre-defined group of individuals.
Participants may receive diagnostic, therapeutic, or other interventions, but the investigator
does not assign specific interventions to the participants of the study.
Expanded Access:
Records describing the procedure for obtaining an experimental drug or device for patients who
are failing on currently available treatments for their condition and also are unable to
participate in ongoing clinical trials. Expanded Access records are used to register all
types of non-protocol access to experimental treatments, including protocol exception,
single-patient IND, treatment IND, compassionate use, emergency use, continued access and parallel track.
Study Results
Searches can be restricted to studies with or without results.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
The inclusion of study results is a relatively new feature of ClinicalTrials.gov. Collection of results began in September of 2008. Almost all older studies and some newer studies do not include results. As time goes on, there will be more results available.
Recruitment Status
Also known as Enrollment Status.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Not all clinical trials in this database are accepting new participants. If you are looking for studies that are currently recruiting participants, will be recruiting in the future, or are about drugs that are available for expanded access, select Open Studies in the recruitment menu.
If you are interested in all trials, whether they are recruiting new participants or not, leave the menu with All Studies selected.
Trials may not be recruiting because they are full, completed, or halted for various reasons. In addition, some trials have very restrictive eligibility requirements and must seek participants by invitation only. To see these studies, Select Closed Studies in the recruitment menu.
Full list of all possible recruitment status values:
Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Search Terms
Use this box to specify general search terms found anywhere in the trial record.
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Multiple terms can be separated by an AND (all uppercase).
Examples:
type ii diabetes
veterans affairs medical center
heart attacks in older adults
nhlbi AND heart disease
Cisplatin AND safety study
Help for Searching clinical trials
Help Topics:
Basic Search:
On the Basic Search page, enter a word or word(s) that you want to use to find studies.
These may include diseases, interventions, and/or locations.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Medical terms are often several words long, such as Percutaneous Coronary Intervention. To only find studies where the words are together as a phrase, put the term in quotes (e.g., "Percutaneous Coronary Intervention"). If you search for a multi-word term without quotes, studies with all words together as a phrase will appear higher in the results list than studies where the words are separated and spread throughout the document. For example, a search for Heart Attack will list a study about,
Use of a Pacemaker Following a Heart Attack.
higher than the study,
Heart Defects and Transient Ischemic Attacks
A search for "Heart Attack" would not find the second study. Synonyms are known for some terms and are used where possible. For example, a search for Heart Attack will also find occurrences of Myocardial Infarction.
Advanced Search:
Many searches are a single term and can be performed with a few words in the
search box. But, sometimes you need more control. Click on the Advanced Search tab
(if starting a new search) or Refine Search tab (if modifying an existing search)
to show additional search fields.
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Recruitment:
Interventions:
Outcomes Measures:
Sponsor/Collaborators:
Sponsor (Lead):
Study IDs:
Country/State:
Location Terms:
Gender:
Age Group:
Phase:
Funded By:
Safety Issue:
First Received:
Last Updated:
The additional search fields can be used to limit your search results. Note that it is not necessary to fill in all the fields, only those that are needed for your search. If you are finding too few studies, consider clearing a field and searching again.
Search Terms:
Performs a general search in all sections of the study record, including title,
description, conditions, interventions, locations, etc. Terms in this field are
searched the same as Basic Search.
Recruitment:
Limits search results to studies that are open or closed. New volunteers may be
able to participate in open studies, but not closed studies.
Open recruitment status values:
Closed recruitment status values:
Values are color coded (as shown) in the search results.
Study Results:Open recruitment status values:
Recruiting,
Not yet recruiting, or
Available for expanded access.
Not yet recruiting, or
Available for expanded access.
Closed recruitment status values:
Active, not recruiting,
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Completed,
Terminated,
Suspended,
Withdrawn,
Enrolling by invitation,
Temporarily not available for expanded access,
No longer available for expanded access,
Approved for marketing, or
Unknown.
Values are color coded (as shown) in the search results.
Limits search results based on whether the study has results or not:
Study Type:
All Studies,
Studies With Results, or
Studies Without Results
The inclusion of Study Results is a new feature of ClinicalTrials.gov.
Only a few studies have results available.Studies With Results, or
Studies Without Results
Limits search results to any of the following study types:
Conditions:
Interventional,
Observational, or
Expanded Access
Observational, or
Expanded Access
Performs a search on fields describing the diseases or conditions being studied.
Interventions:
Performs a search on fields listing the drugs or interventions being studied.
Outcomes Measures:
Performs a search on fields listing the outcome measures used to quantify study results.
Sponsor/Collaborators:
Performs a search on fields listing the sponsor and collaborators of a study.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
When the Exact Match checkbox is checked, the sponsor/collaborator name in the study must exactly match the name in the search. For example, if unchecked, a search for Merck in the sponsor/collaborator field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Sponsor (Lead):
Performs a search on the sponsor field of a study.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
It is common for several organizations to collaborate by providing funding, facilities, experimental treatments, etc. Which organization is considered the "sponsor" is decided by the data provider.
When the Exact Match checkbox is checked, the lead sponsor name in the study must exactly match the lead sponsor name in the search. For example, if unchecked, a search for Merck in the lead sponsor field will find Merck, Merck KGaA, Dupont Merck, and Merck Sharp & Dohme. When checked, only Merck, with no other words in the name, will be found.
Study IDs:
Performs a search on fields listing ID numbers.
Country/State:
Trials are often conducted at many locations around the world.
Select up to three locations to find trials conducted in
specific countries. Some countries (currently limited to the
United States, Canada, and Australia), locations can be narrowed
further by selecting a state (e.g., United States, Alabama).
Location Terms:
Finds studies in specific locations such as a city (Los Angeles) or facility (Mayo Clinic).
Not all studies include this level of detail, but if they do, this will find them.
Gender:
Limits search results to those studies that accept female or male participants.
Age Group:
Limits search results to those studies that include at least one of the specified age
ranges. More than one age group can be selected.
Phase:
Limits search results to studies that are labeled with at least one of the specified
phases. More than one Phase can be selected.
Funded By:
Limits search results to studies that have at least one sponsor of the specified types.
More than one sponsor type can be selected.
Safety Issue:
Limits search results to studies that have at least one outcome measure designated as a safety issue.
First Received:
Limits search results to studies that were received by clinical trials within a
specified date range. The "From" or "To" field can be left blank.
Last Updated:
Limits search results to studies that were modified within a
specified date range. The "From" or "To" field can be left blank.
Refine Search:
Searches display a list of studies found (List Results tab). If you are not content with
the search results, click on the Refine Search tab at the top of the list to modify your
search.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
When you are done making changes, click Search to display the new results.
Add terms to empty fields to search within your current result. You can also add terms to fields that contain terms. For best results, use an AND (all upper case) as a separator between terms in the same field.
For example:
heart attack
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
heart attack AND aspirin
heart attack AND aspirin AND older adults
heart attack AND aspirin AND older adults AND California
When you are done making changes, click Search to display the new results.
Search Expressions:
Use AND (all upper case) to find study records that contain all terms connected by AND.
For example:
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.
For example:
prostate cancer AND radiation
heart disease AND stroke AND California
heart disease AND stroke AND California
Use OR (all upper case) to find study records that contain either term connected by OR.
For example:
Aspirin OR ibuprofen
heart disease OR heart attack
heart disease OR heart attack
Use NOT (all upper case) to find study records that do not contain the term following NOT.
For example:
Immunodeficiency NOT AIDS
Likewise, AND, OR, NOT, and parentheses can be used to create more complicated search expressions.
For example:
prostate cancer AND NOT ( radiation OR homeopathic remedies )
( heart disease OR heart attack ) AND ( stroke OR clot )
( heart disease OR heart attack ) AND ( stroke OR clot )
Note that the use of AND and OR as logical operators can be confusing.
An appropriate search for a list such as,
Ear, Nose, and Throat Conditions
is the expression
( Ear OR Nose OR Throat ) AND Conditions
Fortunately, search will do a pretty good job of finding the right studies either way.To search for AND as a word, instead of using it as an operator, put it in quotes.
Likewise, you can quote OR, NOT, and parentheses.